Since the introduction of the EU clinical trials directive in UK law and the subsequent requirement for a Qualified Person to release pharmaceuticals for clinical trials, it has become apparent that there is a great shortage of QPs in the NHS who are able to perform this task for investigational medical products that are manufactured in hospitals. This is particularly true for radiopharmaceuticals, which, owing to their short shelf-life, nearly always need to be prepared on site and released immediately after manufacture.
展开▼